1.24
Bionano Genomics Inc stock is traded at $1.24, with a volume of 89,198.
It is up +0.00% in the last 24 hours and up +3.33% over the past month.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
See More
Previous Close:
$1.24
Open:
$1.26
24h Volume:
89,198
Relative Volume:
0.30
Market Cap:
$13.75M
Revenue:
$28.51M
Net Income/Loss:
$-26.40M
P/E Ratio:
-0.2265
EPS:
-5.4756
Net Cash Flow:
$-16.35M
1W Performance:
+4.20%
1M Performance:
+3.33%
6M Performance:
-26.63%
1Y Performance:
-68.61%
Bionano Genomics Inc Stock (BNGO) Company Profile
Name
Bionano Genomics Inc
Sector
Industry
Phone
(858) 888-7600
Address
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
Compare BNGO vs ISRG, BDX, MDLN, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
BNGO
Bionano Genomics Inc
|
1.24 | 13.75M | 28.51M | -26.40M | -16.35M | -5.4756 |
|
ISRG
Intuitive Surgical Inc
|
451.38 | 160.21B | 10.58B | 3.00B | 2.83B | 8.2437 |
|
BDX
Becton Dickinson Co
|
144.17 | 41.62B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
MDLN
Medline Inc
|
45.32 | 37.37B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
ALC
Alcon Inc
|
74.45 | 35.82B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
RMD
Resmed Inc
|
207.88 | 30.38B | 5.40B | 1.49B | 1.78B | 10.12 |
Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-15-24 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Sep-10-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Dec-12-22 | Resumed | BTIG Research | Buy |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Jun-16-21 | Initiated | BTIG Research | Buy |
| Sep-24-20 | Initiated | Ladenburg Thalmann | Buy |
| Apr-08-20 | Initiated | Oppenheimer | Outperform |
View All
Bionano Genomics Inc Stock (BNGO) Latest News
Bionano reports 56% jump in rare disease research publications By Investing.com - Investing.com Australia
Bionano reports 56% jump in rare disease research publications - Investing.com
Bionano Announces a 56% Increase in Publications Describing the Utility of OGM in Rare Diseases in Q1 2026 vs Q1 2025 - The Manila Times
28 rare-disease studies back genome mapping for unresolved cases - Stock Titan
BNGO Should I Buy - Intellectia AI
Bionano to Report First Quarter 2026 Financial Results and Host a Conference Call Webcast on May 13, 2026 - The Globe and Mail
Bionano Genomics stock rises on Q1 revenue beat - MSN
Earnings Snapshot: Bionano Genomics sees Q4, FY25 revenue below analysts' consensus - MSN
BNGO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2025 earnings call transcript - MSN
H.C. Wainwright Maintains Bionano Genomics(BNGO.US) With Buy Rating, Cuts Target Price to $6 - Moomoo
BNGO Maintained by HC Wainwright & Co. -- Price Target Lowered t - GuruFocus
Take Profit: Is Bionano Genomics Inc benefiting from interest rate changesWeekly Investment Report & Community Driven Trade Alerts - baoquankhu1.vn
Keys to Succeed in the Booming $300 Million Optical Genome - GlobeNewswire
Breakout Zone: What is Bionano Genomics Incs P E ratio telling us2026 Earnings & Daily Volume Surge Signals - baoquankhu1.vn
Aug Update: Is Bionano Genomics Inc part of any ETFQuarterly Portfolio Report & Weekly High Potential Stock Alerts - baoquankhu1.vn
Bionano Genomics stock price target lowered to $6 by H.C. Wainwright - Investing.com South Africa
Is Bionano (BNGO) Stock Stronger Than Peers | Price at $1.17, Up 1.74%Top Analyst Buy Signals - Cổng thông tin điện tử Tỉnh Sơn La
Weekly Recap: Is Bionano Genomics Inc stock a value trap2026 Big Picture & Real-Time Stock Entry Alerts - baoquankhu1.vn
Analysts Have Conflicting Sentiments on These Healthcare Companies: Johnson & Johnson (JNJ) and BioNano Genomics (BNGO) - The Globe and Mail
Bionano Genomics earnings are imminent; these most accurate analysts revise forecasts ahead of earnings call - MSN
Bionano Genomics, Inc. (BNGO) stock price, news, quote and history - Yahoo Finance Singapore
BNGO Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
BNGO Stock Analysis: Bionano Genomics Inc. holds 1.2 level with mild daily gain in genomics sector - Cổng thông tin điện tử tỉnh Tây Ninh
Bionano Genomics, Inc. (BNGO) Stock Price, News, Quote & History - Yahoo! Finance Canada
[ARS] Bionano Genomics, Inc. SEC Filing - Stock Titan
Bionano Genomics (NASDAQ: BNGO) outlines 2026 virtual meeting and proxy votes - Stock Titan
Aug Highlights: Is Bionano Genomics Inc benefiting from interest rate changes2026 Buyback Activity & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma - Bitget
In 211 myeloma samples, OGM found abnormalities older tests missed - Stock Titan
Q4 2024 Bionano Genomics Inc Earnings Call Transcript - GuruFocus
BNGO Stock Analysis: Bionano Genomics Inc logs 1.71 pct gain to 1.19 in biotech - Cổng thông tin điện tử Tỉnh Sơn La
Volume Summary: Is Bionano Genomics Inc backed by strong institutional buying2026 PostEarnings & Real-Time Stock Price Movement Reports - baoquankhu1.vn
Profit Review: Is Bionano Genomics Inc part of any ETFWeekly Trade Recap & High Accuracy Buy Signal Tips - baoquankhu1.vn
Bionano outlines $30M–$33M revenue target for 2026 with focus on routine user growth and margin expansion - MSN
Bionano Genomics, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:BNGO) 2026-03-24 - Seeking Alpha
Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2025 Earnings Call Transcript - Insider Monkey
Bionano Genomics Reports 2025 Financial Results, Highlights OGM Adoption and Announces 2026 Revenue Outlook - minichart.com.sg
Bionano Genomics 2025 Annual Report Highlights: Optical Genome Mapping, Market Expansion, and Risk Factors 57596054 - Minichart
Bionano Genomics Inc Stock (BNGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):